FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004269416> ?p ?o ?g. }

• W2004269416 endingPage "460" @default.
• W2004269416 startingPage "452" @default.
• W2004269416 abstract "In the current study, the effect of a highly specific peptide inhibitor of glycogen synthase kinase 3 (GSK3) (L803-mts) on glucose metabolism and BP was examined in a high-fat (HF) fed mouse model of diabetes. C57/BL6J mice were placed on an HF diet for 3 months and treated with L803-mts for 20 days, following which glucose metabolism was examined by euglycaemic–hyperinsulinaemic clamp studies. BP and heart rate were measured by radio-telemetry. The HF mice were obese, with impaired glucose tolerance and high plasma insulin and leptin levels. L803-mts treatment significantly reduced the insulin levels and doubled the glucose infusion rate required to maintain a euglycaemic condition in the HF+L803-mts group compared with the HF group. Insulin failed to suppress the endogenous glucose production rate in the HF group while decreasing it by 75% in the HF+L803-mts group, accompanied by increased liver glycogen synthase activity and net hepatic glycogen synthesis. GSK3 inhibition also reduced peripheral insulin resistance. Plasma glucose disappearance rate increased by 60% in the HF+L803-mts group compared with the HF group. In addition, glucose uptake in heart and gastrocnemius muscle was markedly improved. Although mean arterial pressure increased following the HF diet, it did not change significantly during the 12 days of L803-mts treatment. These studies demonstrate that GSK3 inhibition improved hepatic and peripheral insulin resistance in a mouse model of HF-induced diabetes, but it failed to have an effect on BP. GSK3 may represent an important therapeutic target for insulin resistance." @default.
• W2004269416 created "2016-06-24" @default.
• W2004269416 creator A5002368934 @default.
• W2004269416 creator A5018965795 @default.
• W2004269416 creator A5025336530 @default.
• W2004269416 creator A5029763432 @default.
• W2004269416 creator A5048018294 @default.
• W2004269416 creator A5071722069 @default.
• W2004269416 date "2006-12-07" @default.
• W2004269416 modified "2023-10-17" @default.
• W2004269416 title "Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice" @default.
• W2004269416 cites W1490814708 @default.
• W2004269416 cites W1555947589 @default.
• W2004269416 cites W1890261708 @default.
• W2004269416 cites W189099665 @default.
• W2004269416 cites W1930499844 @default.
• W2004269416 cites W1975815687 @default.
• W2004269416 cites W1980198526 @default.
• W2004269416 cites W1982723196 @default.
• W2004269416 cites W1983435458 @default.
• W2004269416 cites W1988605096 @default.
• W2004269416 cites W1997937533 @default.
• W2004269416 cites W2001866120 @default.
• W2004269416 cites W2014982455 @default.
• W2004269416 cites W2019041110 @default.
• W2004269416 cites W2019802189 @default.
• W2004269416 cites W2029160178 @default.
• W2004269416 cites W2032202625 @default.
• W2004269416 cites W2058138221 @default.
• W2004269416 cites W2066287788 @default.
• W2004269416 cites W2071154296 @default.
• W2004269416 cites W2089172994 @default.
• W2004269416 cites W2098017074 @default.
• W2004269416 cites W2109326550 @default.
• W2004269416 cites W2109479865 @default.
• W2004269416 cites W2112820874 @default.
• W2004269416 cites W2113438957 @default.
• W2004269416 cites W2123814156 @default.
• W2004269416 cites W2128282444 @default.
• W2004269416 cites W2130357785 @default.
• W2004269416 cites W2139997006 @default.
• W2004269416 cites W2148769969 @default.
• W2004269416 cites W2149791342 @default.
• W2004269416 cites W2151522859 @default.
• W2004269416 cites W2153250061 @default.
• W2004269416 cites W2153302582 @default.
• W2004269416 cites W2154197060 @default.
• W2004269416 cites W2156420000 @default.
• W2004269416 cites W2161084851 @default.
• W2004269416 cites W2164664153 @default.
• W2004269416 cites W2170537843 @default.
• W2004269416 cites W2178233651 @default.
• W2004269416 cites W2302447233 @default.
• W2004269416 cites W2319850088 @default.
• W2004269416 cites W2338244159 @default.
• W2004269416 cites W9158152 @default.
• W2004269416 doi "https://doi.org/10.1007/s00125-006-0552-5" @default.
• W2004269416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17151860" @default.
• W2004269416 hasPublicationYear "2006" @default.
• W2004269416 type Work @default.
• W2004269416 sameAs 2004269416 @default.
• W2004269416 citedByCount "65" @default.
• W2004269416 countsByYear W20042694162012 @default.
• W2004269416 countsByYear W20042694162013 @default.
• W2004269416 countsByYear W20042694162014 @default.
• W2004269416 countsByYear W20042694162015 @default.
• W2004269416 countsByYear W20042694162016 @default.
• W2004269416 countsByYear W20042694162017 @default.
• W2004269416 countsByYear W20042694162019 @default.
• W2004269416 countsByYear W20042694162020 @default.
• W2004269416 countsByYear W20042694162021 @default.
• W2004269416 countsByYear W20042694162022 @default.
• W2004269416 countsByYear W20042694162023 @default.
• W2004269416 crossrefType "journal-article" @default.
• W2004269416 hasAuthorship W2004269416A5002368934 @default.
• W2004269416 hasAuthorship W2004269416A5018965795 @default.
• W2004269416 hasAuthorship W2004269416A5025336530 @default.
• W2004269416 hasAuthorship W2004269416A5029763432 @default.
• W2004269416 hasAuthorship W2004269416A5048018294 @default.
• W2004269416 hasAuthorship W2004269416A5071722069 @default.
• W2004269416 hasBestOaLocation W20042694161 @default.
• W2004269416 hasConcept C126322002 @default.
• W2004269416 hasConcept C134018914 @default.
• W2004269416 hasConcept C17093226 @default.
• W2004269416 hasConcept C182996813 @default.
• W2004269416 hasConcept C184235292 @default.
• W2004269416 hasConcept C192118531 @default.
• W2004269416 hasConcept C2777391703 @default.
• W2004269416 hasConcept C2777499176 @default.
• W2004269416 hasConcept C2778808658 @default.
• W2004269416 hasConcept C2779306644 @default.
• W2004269416 hasConcept C2780352109 @default.
• W2004269416 hasConcept C55493867 @default.
• W2004269416 hasConcept C555293320 @default.
• W2004269416 hasConcept C71924100 @default.
• W2004269416 hasConcept C86803240 @default.
• W2004269416 hasConceptScore W2004269416C126322002 @default.
• W2004269416 hasConceptScore W2004269416C134018914 @default.

• next